Raphael Ognar

Raphael Ognar

Company: NKILT Therapeutics

Job title: President & CEO, Co-Founder - Chairman of the Board

Seminars:

Harnessing Chimeric ILT-Receptor Binding Technology to Target the HLA-G Pathway for Fit-for-Purpose Activation of NK Cells 4:45 pm

Download the event guide for full session detailsRead more

day: Day Two

Panel Discussion: Contrasting Current & Emerging Engineering Strategies to Target Solid Tumors 2:30 pm

Download the event guide for full session detailsRead more

day: Day One Track A PM

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.